Vincerx Pharma, Inc.

VINC · NASDAQ
Analyze with AI
3/31/2025
12/31/2024
9/30/2024
6/30/2024
Operating Activities
Net Income-$5-$8-$8-$2
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$1$1$1
Change in WC-$2$1-$0$0
Other Non-Cash$2-$1$0-$5
Operating Cash Flow-$4-$6-$6-$6
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0-$3-$8
Inv. Sales/Matur.$0$7$5$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$7$1-$8
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$4$1-$17$17
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$4$1$0$17
Forex Effect$0$0$0-$0
Net Chg. in Cash-$1$2-$5$3
Supplemental Information
Beg. Cash$5$3$8$5
End Cash$5$5$3$8
Free Cash Flow-$4-$6-$6-$6
Vincerx Pharma, Inc. (VINC) Financial Statements & Key Stats | AlphaPilot